GO:1904504

BP

positive regulation of lipophagy

Any process that activates or increases the frequency, rate or extent of lipophagy.

SPTLC2, ADRB2, HTT

GO:1904527

BP

negative regulation of microtubule binding

Any process that stops, prevents or reduces the frequency, rate or extent of microtubule binding.

MAPRE1, GTSE1

GO:1904528

BP

positive regulation of microtubule binding

Any process that activates or increases the frequency, rate or extent of microtubule binding.

HSF1

GO:1904544

BP

positive regulation of free ubiquitin chain polymerization

Any process that activates or increases the frequency, rate or extent of free ubiquitin chain polymerization.

PINK1

GO:1904562

BP

phosphatidylinositol 5-phosphate metabolic process

The chemical reactions and pathways involving phosphatidylinositol 5-phosphate.

PIKFYVE

GO:1904568

BP

cellular response to wortmannin

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a wortmannin stimulus.

CDC5L

GO:1904582

BP

positive regulation of intracellular mRNA localization

Any process that activates or increases the frequency, rate or extent of intracellular mRNA localization.

ZFP36, ZFP36L1

GO:1904586

BP

cellular response to putrescine

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a putrescine stimulus.

HNRNPD

GO:1904591

BP

positive regulation of protein import

Any process that activates or increases the frequency, rate or extent of protein import.

ARHGEF5

GO:1904628

BP

cellular response to phorbol 13-acetate 12-myristate

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phorbol 13-acetate 12-myristate stimulus.

RPLP0, ZFP36L2, CDK6, ZFP36L1

GO:1904635

BP

positive regulation of glomerular visceral epithelial cell apoptotic process

Any process that activates or increases the frequency, rate or extent of glomerular visceral epithelial cell apoptotic process.

PPARGC1A

GO:1904637

BP

cellular response to ionomycin

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ionomycin stimulus.

PPARGC1A

GO:1904639

BP

cellular response to resveratrol

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a resveratrol stimulus.

PPARGC1A

GO:1904640

BP

response to methionine

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methionine stimulus.

PCK1, PPARGC1A

GO:1904646

BP

cellular response to beta-amyloid

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a beta-amyloid stimulus.

FOXO3, PARP1, CASP4

GO:1904651

BP

positive regulation of fat cell apoptotic process

Any process that activates or increases the frequency, rate or extent of fat cell apoptotic process.

LEP

GO:1904659

BP

glucose transmembrane transport

The directed movement of glucose across a membrane.

SLC2A10, PPBP, SLC2A1, SLC2A3, SLC2A4, SLC2A5, MFSD4B, SLC2A14, SLC2A6

GO:1904667

BP

negative regulation of ubiquitin protein ligase activity

Any process that stops, prevents or reduces the frequency, rate or extent of ubiquitin protein ligase activity.

MAD2L1, USP44

GO:1904668

BP

positive regulation of ubiquitin protein ligase activity

Any process that activates or increases the frequency, rate or extent of ubiquitin protein ligase activity.

UBE2C, CDC14B, PLK1, PTEN, CDC20, UBE2S, FZR1

GO:1904681

BP

response to 3-methylcholanthrene

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 3-methylcholanthrene stimulus.

CHKA

GO:1904684

BP

negative regulation of metalloendopeptidase activity

Any process that stops, prevents or reduces the frequency, rate or extent of metalloendopeptidase activity.

RECK, TIMP3

GO:1904685

BP

positive regulation of metalloendopeptidase activity

Any process that activates or increases the frequency, rate or extent of metalloendopeptidase activity.

STAT3

GO:1904693

BP

midbrain morphogenesis

The developmental process by which a midbrain is generated and organized.

FZD6, SOS1

GO:1904694

BP

negative regulation of vascular smooth muscle contraction

Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle contraction.

ARHGAP42, DOCK5

GO:1904706

BP

negative regulation of vascular smooth muscle cell proliferation

Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell proliferation.

GSTP1, TPM1, HMOX1, IL10, CDKN1B, CNN1, GPER1

GO:1904707

BP

positive regulation of vascular smooth muscle cell proliferation

Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation.

JAK2, ERN1, AGT, PDGFB, MMP2, MMP9, NQO2, IL10, BMPR1A, MDM2, MAP3K5

GO:1904708

BP

regulation of granulosa cell apoptotic process

Any process that modulates the frequency, rate or extent of granulosa cell apoptotic process.

BOK

GO:1904714

BP

regulation of chaperone-mediated autophagy

Any process that modulates the frequency, rate or extent of chaperone-mediated autophagy.

EEF1A1, EEF1A2, ATP13A2

GO:1904715

BP

negative regulation of chaperone-mediated autophagy

Any process that stops, prevents or reduces the frequency, rate or extent of chaperone-mediated autophagy.

SNCA

GO:1904722

BP

positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response

Any process that activates or increases the frequency, rate or extent of mRNA endonucleolytic cleavage involved in unfolded protein response.

HSPA1A, HSPA1B

GO:1904723

BP

negative regulation of Wnt-Frizzled-LRP5/6 complex assembly

Any process that stops, prevents or reduces the frequency, rate or extent of Wnt-Frizzled-LRP5/6 complex assembly.

DKK1

GO:1904733

BP

negative regulation of electron carrier activity

Any process that stops, prevents or reduces the frequency, rate or extent of electron carrier activity.

ETFBKMT

GO:1904736

BP

negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase

Any process that stops, prevents or reduces the frequency, rate or extent of fatty acid beta-oxidation using acyl-CoA dehydrogenase.

ETFBKMT

GO:1904743

BP

negative regulation of telomeric DNA binding

Any process that stops, prevents or reduces the frequency, rate or extent of telomeric DNA binding.

TNKS

GO:1904753

BP

negative regulation of vascular associated smooth muscle cell migration

Any process that stops, prevents or reduces the frequency, rate or extent of vascular associated smooth muscle cell migration.

TPM1

GO:1904754

BP

positive regulation of vascular associated smooth muscle cell migration

Any process that activates or increases the frequency, rate or extent of vascular associated smooth muscle cell migration.

AGT, PDGFB, IQGAP1, MDM2, DOCK7, DOCK5

GO:1904761

BP

negative regulation of myofibroblast differentiation

Any process that stops, prevents or reduces the frequency, rate or extent of myofibroblast differentiation.

PDCD4

GO:1904762

BP

positive regulation of myofibroblast differentiation

Any process that activates or increases the frequency, rate or extent of myofibroblast differentiation.

PARP1

GO:1904772

BP

response to tetrachloromethane

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tetrachloromethane stimulus.

EZH2

GO:1904792

BP

positive regulation of telosome assembly

Any process that activates or increases the frequency, rate or extent of telosome assembly.

TERF1

GO:1904793

BP

regulation of euchromatin binding

Any process that modulates the frequency, rate or extent of euchromatin binding.

CTNNB1

GO:1904796

BP

regulation of core promoter binding

Any process that modulates the frequency, rate or extent of core promoter binding.

CTNNB1

GO:1904808

BP

positive regulation of protein oxidation

Any process that activates or increases the frequency, rate or extent of protein oxidation.

TRABD2A

GO:1904815

BP

negative regulation of protein localization to chromosome, telomeric region

Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to chromosome, telomeric region.

H2AFY

GO:1904816

BP

positive regulation of protein localization to chromosome, telomeric region

Any process that activates or increases the frequency, rate or extent of protein localization to chromosome, telomeric region.

GNL3, GNL3L

GO:1904823

BP

purine nucleobase transmembrane transport

The directed movement of purine nucleobase across a membrane.

AQP9, SLC28A3

GO:1904831

BP

positive regulation of aortic smooth muscle cell differentiation

Any process that activates or increases the frequency, rate or extent of aortic smooth muscle cell differentiation.

CTH

GO:1904835

BP

dorsal root ganglion morphogenesis

The developmental process by which a dorsal root ganglion is generated and organized.

NRP1

GO:1904837

BP

beta-catenin-TCF complex assembly

The aggregation, arrangement and bonding together of a set of components to form a beta-catenin-TCF complex.

MYC, CTNNB1, SMARCA4, HIST1H4A, TLE1, TLE3, EP300, HDAC1, RBBP5, CREBBP, PYGO2, TCF7L1, TCF7L2, ASH2L, RUVBL1, TRRAP

GO:1904843

BP

cellular response to nitroglycerin

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitroglycerin stimulus.

HSF1

GO:1904845

BP

cellular response to L-glutamine

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a L-glutamine stimulus.

CYBB, HSF1

GO:1904850

BP

negative regulation of establishment of protein localization to telomere

Any process that stops, prevents or reduces the frequency, rate or extent of establishment of protein localization to telomere.

TERF1

GO:1904851

BP

positive regulation of establishment of protein localization to telomere

Any process that activates or increases the frequency, rate or extent of establishment of protein localization to telomere.

DKC1, TCP1, CCT6A, CCT8, CCT2, CCT7

GO:1904861

BP

excitatory synapse assembly

The aggregation, arrangement and bonding together of a set of components to form an excitatory synapse.

WNT5A, NLGN1

GO:1904862

BP

inhibitory synapse assembly

The aggregation, arrangement and bonding together of a set of components to form an inhibitory synapse.

WNT5A

GO:1904864

BP

negative regulation of beta-catenin-TCF complex assembly

Any process that stops, prevents or reduces the frequency, rate or extent of beta-catenin-TCF complex assembly.

DACT1

GO:1904871

BP

positive regulation of protein localization to Cajal body

Any process that activates or increases the frequency, rate or extent of protein localization to Cajal body.

TCP1, CCT6A, CCT3, CCT8, CCT2, CCT7

GO:1904874

BP

positive regulation of telomerase RNA localization to Cajal body

Any process that activates or increases the frequency, rate or extent of telomerase RNA localization to Cajal body.

DKC1, TCP1, CCT6A, CCT3, CCT8, CCT2, SHQ1, NAF1, CCT7, NOP10, RUVBL2, RUVBL1

GO:1904879

BP

positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel

Any process that activates or increases the frequency, rate or extent of calcium ion transmembrane transport via high voltage-gated calcium channel.

G6PD

GO:1904885

BP

beta-catenin destruction complex assembly

The aggregation, arrangement and bonding together of a set of components to form a beta-catenin destruction complex.

AXIN1, APC, CSNK1A1, GSK3B

GO:1904886

BP

beta-catenin destruction complex disassembly

The disaggregation of a beta-catenin destruction complex into its constituent components.

AXIN1, LRP5, LRP6, APC, CTNNB1, CSNK1A1, GSK3B, PPP1CA, CAV1

GO:1904888

BP

cranial skeletal system development

The process whose specific outcome is the progression of a cranial skeletal system over time, from its formation to the mature structure. The cranial skeletal system is the skeletal subdivision of the head, and includes the skull (cranium plus mandible), pharyngeal and/or hyoid apparatus.

CTNNB1, TGFB2

GO:1904903

BP

ESCRT III complex disassembly

The disaggregation of an ESCRT III complex into its constituent components.

CHMP2A, VPS4B, IST1, VTA1

GO:1904908

BP

negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric

Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion, telomeric.

TNKS, ATRX

GO:1904911

BP

negative regulation of establishment of RNA localization to telomere

Any process that stops, prevents or reduces the frequency, rate or extent of establishment of RNA localization to telomere.

TERF1

GO:1904914

BP

negative regulation of establishment of macromolecular complex localization to telomere

Any process that stops, prevents or reduces the frequency, rate or extent of establishment of macromolecular complex localization to telomere.

TERF1

GO:1904934

BP

negative regulation of cell proliferation in midbrain

Any process that stops, prevents or reduces the frequency, rate or extent of cell proliferation in midbrain.

WNT5A

GO:1904938

BP

planar cell polarity pathway involved in axon guidance

Any Wnt signaling pathway, planar cell polarity pathway that is involved in axon guidance.

WNT5A, CELSR3

GO:1904948

BP

midbrain dopaminergic neuron differentiation

The process in which a relatively unspecialized cell acquires the specialized features of a midbrain dopaminergic neuron.

LRP6, WNT2, CTNNB1, NR4A2, RAC1

GO:1904953

BP

Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation

Any Wnt signaling pathway that is involved in midbrain dopaminergic neuron differentiation.

LRP6, WNT5A

GO:1904954

BP

canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation

Any canonical Wnt signaling pathway that is involved in midbrain dopaminergic neuron differentiation.

WNT2, CTNNB1

GO:1904955

BP

planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation

Any Wnt signaling pathway, planar cell polarity pathway that is involved in midbrain dopaminergic neuron differentiation.

WNT5A

GO:1904956

BP

regulation of midbrain dopaminergic neuron differentiation

Any process that modulates the frequency, rate or extent of midbrain dopaminergic neuron differentiation.

SFRP1

GO:1904958

BP

positive regulation of midbrain dopaminergic neuron differentiation

Any process that activates or increases the frequency, rate or extent of midbrain dopaminergic neuron differentiation.

DKK1

GO:1904980

BP

positive regulation of endosome organization

Any process that activates or increases the frequency, rate or extent of endosome organization.

SYNJ1

GO:1904988

BP

negative regulation of endothelial cell activation

Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell activation.

SOCS5

GO:1904996

BP

positive regulation of leukocyte adhesion to vascular endothelial cell

Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to vascular endothelial cell.

TNF, ETS1

GO:1904998

BP

negative regulation of leukocyte adhesion to arterial endothelial cell

Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte adhesion to arterial endothelial cell.

KLF4

GO:1904999

BP

positive regulation of leukocyte adhesion to arterial endothelial cell

Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to arterial endothelial cell.

TNF

GO:1905006

BP

negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation

Any process that stops, prevents or reduces the frequency, rate or extent of epithelial to mesenchymal transition involved in endocardial cushion formation.

TGFB2

GO:1905007

BP

positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation

Any process that activates or increases the frequency, rate or extent of epithelial to mesenchymal transition involved in endocardial cushion formation.

TGFBR1, TGFBR2, TGFB2, ACVR1

GO:1905010

BP

positive regulation of L-lysine import into cell

Any process that activates or increases the frequency, rate or extent of L-lysine import into cell.

AGT

GO:1905037

BP

autophagosome organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an autophagosome.

ATP13A2

GO:1905039

BP

carboxylic acid transmembrane transport

The directed movement of carboxylic acid across a membrane.

AQP9

GO:1905040

BP

otic placode development

The process whose specific outcome is the progression of an otic placode over time, from its formation to the mature structure.

NRP1

GO:1905053

BP

positive regulation of base-excision repair

Any process that activates or increases the frequency, rate or extent of base-excision repair.

FAM168A

GO:1905064

BP

negative regulation of vascular smooth muscle cell differentiation

Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation.

PDGFB

GO:1905065

BP

positive regulation of vascular smooth muscle cell differentiation

Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation.

KIT

GO:1905075

BP

positive regulation of occluding junction disassembly

Any process that activates or increases the frequency, rate or extent of occluding junction disassembly.

TGFBR1

GO:1905090

BP

negative regulation of parkin-mediated mitophagy in response to mitochondrial depolarization

Any process that stops, prevents or reduces the frequency, rate or extent of parkin-mediated mitophagy in response to mitochondrial depolarization.

VPS13C

GO:1905098

BP

negative regulation of guanyl-nucleotide exchange factor activity

Any process that stops, prevents or reduces the frequency, rate or extent of guanyl-nucleotide exchange factor activity.

EIF2S1

GO:1905122

BP

polyamine import

The directed movement of polyamine macromolecule into a cell or organelle.

ATP13A2

GO:1905123

BP

regulation of glucosylceramidase activity

Any process that modulates the frequency, rate or extent of glucosylceramidase activity.

ATP13A2

GO:1905143

BP

eukaryotic translation initiation factor 2 complex assembly

The aggregation, arrangement and bonding together of a set of components to form an eukaryotic translation initiation factor 2 complex.

CDC123

GO:1905150

BP

regulation of voltage-gated sodium channel activity

Any process that modulates the frequency, rate or extent of voltage-gated sodium channel activity.

FGF12

GO:1905154

BP

negative regulation of membrane invagination

Any process that stops, prevents or reduces the frequency, rate or extent of membrane invagination.

SYT11

GO:1905162

BP

regulation of phagosome maturation

Any process that modulates the frequency, rate or extent of phagosome maturation.

SYT11

GO:1905165

BP

regulation of lysosomal protein catabolic process

Any process that modulates the frequency, rate or extent of lysosomal protein catabolic process.

ATP13A2

GO:1905166

BP

negative regulation of lysosomal protein catabolic process

Any process that stops, prevents or reduces the frequency, rate or extent of lysosomal protein catabolic process.

ATP13A2

GO:1905171

BP

positive regulation of protein localization to phagocytic vesicle

Any process that activates or increases the frequency, rate or extent of protein localization to phagocytic vesicle.

SYT11